STI Diagnosis: Hepatitis C — What a Positive Result Actually Means

Hepatitis C is curable. That's the headline, and it's worth sitting with before anything else: HCV went from a life-altering chronic illness to a routinely treatable infection in the space of a decade. A short course of tablets. Cure rates above 95%. That is the modern reality of this diagnosis.

What this guide covers is the part between getting the result and finishing treatment — understanding what your specific result means, what treatment actually involves, and a few things that tend to catch people off guard.

🔩 Reading Your Results: Antibody vs. RNA

HCV testing works in two steps, and a lot of confusion comes from not knowing which test you had.

Anti-HCV (antibody test): This is the standard screening test. A positive result means your immune system has made antibodies to HCV at some point — which means you've been exposed. It does not tell you whether the infection is currently active. It also doesn't clear after successful treatment: once your body makes anti-HCV antibodies, they stay in your blood permanently. A positive antibody test years after a successful cure is still a positive antibody test.

HCV RNA (viral load test): This confirms whether the virus is actually active in your body right now. A positive RNA means current, active infection. A negative RNA after a positive antibody means either you cleared the infection naturally, or you've been successfully treated in the past.

The result combinations and what they mean:

If your antibody test is positive and you haven't had an RNA test yet, that's the next step. Don't treat a positive antibody result as a confirmed active infection — and don't treat it as nothing. Get the RNA confirmed.

Window period: HCV antibodies can take 8–12 weeks to appear after infection. If you had a specific high-risk exposure recently and the antibody test is negative, test again at 12 weeks. For earlier detection of a recent exposure, an RNA test can turn positive within 1–2 weeks of infection.

🔩 Acute vs. Chronic: Where You Are in the Timeline

Acute HCV is an infection acquired within the last 6 months. In roughly 20–45% of people, the immune system clears it naturally during this window — no treatment needed, just monitoring. How do you know if you're in this group? You don't, yet — which is why acute infections are monitored rather than immediately treated in some clinical settings, while others recommend early treatment to guarantee clearance.

Ask your doctor explicitly: "Is there any reason to wait, or should we treat now?" The calculus varies by country, clinical guidelines, and your individual viral load and liver function picture.

Chronic HCV is defined as infection persisting beyond 6 months. This is what most people are dealing with at diagnosis, because HCV produces almost no symptoms in the acute phase — the majority of people have no idea they've been infected until a blood test picks it up, often months or years later.

The fact that you may have had HCV for a while before finding out does not change the outcome. Treatment at any stage of chronic HCV is highly effective. Earlier is better for liver health, but "late" diagnosis followed by successful treatment still means cure.

🟢 Treatment: What It Actually Involves

Modern HCV treatment uses direct-acting antivirals (DAAs) — oral tablets, taken once daily, for 8–12 weeks depending on the regimen and your specific situation.

The main regimens in wide use:

• Sofosbuvir/velpatasvir (Epclusa): Pan-genotypic — works across all HCV genotypes. 12 weeks.
• Glecaprevir/pibrentasvir (Maviret): Pan-genotypic. 8 weeks for most people without significant liver damage.

Both are well-tolerated. Side effects exist but are generally mild — fatigue and headache are the most commonly reported. Most people complete the course without significant disruption to daily life.

What "cured" means — SVR: Treatment success is measured by SVR (sustained virological response) — undetectable HCV RNA 12 weeks after finishing treatment. SVR is considered a cure: the virus does not reactivate, and it does not cause further liver damage. This is not "managed" in the way HIV or chronic HBV is managed. The virus is gone.

Being cured does not give you immunity. HCV does not generate the kind of lasting immune protection that prevents reinfection. If you're reexposed through the same routes — fisting, rough anal sex with tissue trauma, shared equipment — you can acquire HCV again. Post-treatment testing continues on the same schedule as before.

Genotype testing: Older HCV treatments were genotype-specific. Pan-genotypic DAAs largely remove that requirement, but some clinics still run genotype testing as part of the workup. It won't change your treatment in most cases, but it may be part of your clinic's standard protocol.

⚠️ Access to Treatment

Treatment access varies significantly by country and by healthcare system.

In most of Western Europe, Australia, and New Zealand, DAA treatment is now widely available through public health systems, often with minimal or no cost. In practice, sexual health clinics and HIV clinics (if you're in one) tend to be the fastest route — they're familiar with the treatment pathway and can initiate it without a long specialist referral chain.

In other countries, access is more variable — cost, specialist gatekeeping, and insurance requirements can all be factors.

What to say at the clinic: "I've had a confirmed HCV RNA positive. I'd like to discuss starting DAA treatment and understand what my access looks like here."

If your primary care doctor isn't experienced with HCV treatment, ask for a referral to a hepatologist, gastroenterologist, or infectious disease specialist. You don't have to accept a prolonged wait — this is a curable infection with effective treatment available.

Country-specific access information is in the regional guides.

🛡️ Looking After Your Liver During and After Treatment

The liver is what HCV affects, and it deserves specific attention regardless of where you are in the treatment timeline.

Alcohol: HCV causes liver inflammation. Alcohol does too. The combination accelerates liver damage more than either alone. During active infection, keeping alcohol low or eliminating it is the most impactful thing you can do outside of treatment itself. After successful treatment, the liver can recover significantly — but ongoing heavy drinking undermines that recovery.

Liver function monitoring: Your doctor will track ALT and AST (liver enzymes) as markers of inflammation, and may arrange an ultrasound or fibroscan to assess the degree of any liver scarring. If there's significant fibrosis or cirrhosis, monitoring continues even after cure — the structural damage doesn't reverse overnight, and the risk of liver cancer (HCC) in people with advanced cirrhosis persists even after HCV clearance.

Hepatitis A and B: Co-infection with HAV or HBV makes liver outcomes worse. If you're not immune to Hep A and Hep B, get vaccinated — particularly during active HCV infection when the liver is already under stress. This is a conversation to have with your doctor at the same appointment.

HIV co-infection: HIV and HCV share transmission routes and co-infection is common. If you're HIV-positive and on antiretrovirals, some regimens interact with HCV DAAs — your HIV clinic needs to be involved in the HCV treatment decision, not sidelined. If you're not tested for HIV, now is a good time.

🔁 After Cure: What Changes

Once SVR is confirmed — HCV RNA undetectable 12 weeks post-treatment — you've cleared the virus. No maintenance treatment, no ongoing antivirals, no monitoring of HCV specifically. That chapter is closed.

What continues:

• Reinfection testing: If fisting, chemsex, rough anal sex, or shared equipment remain part of your life, HCV testing stays on your quarterly STI panel. SVR is not immunity.
• Liver monitoring: If treatment found any significant scarring, your doctor will advise ongoing liver surveillance. For people treated early with minimal liver damage, no further liver-specific monitoring may be needed.
• The antibody stays positive: Anti-HCV will remain positive indefinitely. This sometimes causes confusion at future testing — it's not a sign of active infection, it's a permanent record of past exposure. Any future clinic or doctor should know your history so they run the RNA rather than stopping at the antibody.

🟢 The Emotional Side

HCV has a specific emotional profile that's worth naming, because it's different from most other STI diagnoses.

The most common one is the delayed diagnosis problem: finding out you've had an infection — potentially for months or years — without knowing. That tends to generate a particular kind of retrospective anxiety: who did I transmit it to? How long have I had it? Why didn't I pick it up sooner? Those questions are real, and they're worth working through, but they don't change the treatment picture or the outcome.

There's also sometimes a stigma response around the practices associated with HCV transmission in the MSM context — fisting and chemsex carry their own social weight in some communities. Having HCV can feel like it says something about how you have sex. It doesn't. It says you were unlucky during a contact sport where this particular virus found a route in. The same calculation applies to everyone who has sex.

If the diagnosis brings up significant anxiety, shame, or a difficulty with the retrospective uncertainty — talking to someone is more useful than processing it alone. Most sexual health clinics have counsellors or can refer you to someone with relevant experience.

Related: